Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma

Abstract excerpt

BACKGROUND: Neuroblastoma is the most common extracranial solid tumour in children, accounting for 15% of paediatric cancer deaths. Multiple genetic abnormalities have been identified as prognostically significant in neuroblastoma patients. Optical genome mapping (OGM) is a novel cytogenetic technique used to detect structural variants, which has not previously been tested in neuroblastoma. We used OGM to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Microtubule and mitosis dynamics
• Share to Neuroblastoma Research and Treatments
• Share to Neurofibromatosis and Schwannoma Cases